Basal cell subsets, as biomarker to predict the therapeutic effect of neoadjuvant therapy for esophageal carcinoma
- DOI
- 10.1007/s00432-026-06503-y
- Published
- 2026-05-19
- Container
- Journal of Cancer Research and Clinical Oncology
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1007/s00432-026-06503-y,
title = {Basal cell subsets, as biomarker to predict the therapeutic effect of neoadjuvant therapy for esophageal carcinoma},
author = {Xiangbing Xin and Jiayu Lu and Xuxu Zhang and Jipeng Zhang and Yiming Li and Xinyao Xu and Jiahe Li and Li Gong and Qiang lu},
year = {2026},
journal = {Journal of Cancer Research and Clinical Oncology},
doi = {10.1007/s00432-026-06503-y},
url = {https://doi.org/10.1007/s00432-026-06503-y}
}RIS
TY - JOUR TI - Basal cell subsets, as biomarker to predict the therapeutic effect of neoadjuvant therapy for esophageal carcinoma AU - Xiangbing Xin AU - Jiayu Lu AU - Xuxu Zhang AU - Jipeng Zhang AU - Yiming Li AU - Xinyao Xu AU - Jiahe Li AU - Li Gong AU - Qiang lu PY - 2026 JO - Journal of Cancer Research and Clinical Oncology DO - 10.1007/s00432-026-06503-y UR - https://doi.org/10.1007/s00432-026-06503-y ER -
APA
Xin, X., Lu, J., Zhang, X., Zhang, J., Li, Y., Xu, X., Li, J., Gong, L., & lu, Q. (2026). Basal cell subsets, as biomarker to predict the therapeutic effect of neoadjuvant therapy for esophageal carcinoma. Journal of Cancer Research and Clinical Oncology. https://doi.org/10.1007/s00432-026-06503-y
Source records
- crossref · retrieved 2026-09-25T10:42:28.422Z